PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
02-Mar-2026 Avant Brands Reports Audited Fiscal 2025 Results with 19% Recreational Revenue Growth ACCESS Newswire
02-Mar-2026 Genflow Biosciences PLC Announces Result of GM ACCESS Newswire
02-Mar-2026 Bioanalytical Services Market Executive Summary, Segmentation, Review, Trends, Opportunities, Growth, Demand and Forecast to 2031 Medi-Tech Insights
02-Mar-2026 Medical Waste Management Market Production Analysis, Opportunity Assessments, Market Revenue, Advancement Strategy and Geographical Performance Forecast to 2031 Medi-Tech Insights
02-Mar-2026 Patient Registry Software Market Executive Summary, Segmentation, Review, Trends, Opportunities, Growth, Demand and Forecast to 2031 Medi-Tech Insights
02-Mar-2026 Healthcare Staffing Market Executive Summary, Segmentation, Review, Trends, Opportunities, Growth, Demand and Forecast to 2031 Medi-Tech Insights
02-Mar-2026 Medical Display Market: Global Market Growth Study, Future Trends, Demands, and Top Players Data by Forecast to 2031 Medi-Tech Insights
02-Mar-2026 Faron Pharmaceuticals Ltd: Results of the Extraordinary General Meeting ACCESS Newswire
02-Mar-2026 IRLAB Participates in Life Science Day in Gothenburg on March 4, 2026 ACCESS Newswire
02-Mar-2026 Alligator Bioscience Comments on Henlius Dosing First Patient in Phase 2/3 Breast Cancer Study of HLX22 ACCESS Newswire
02-Mar-2026 Otsuka Medical Devices/Otsuka Pharmaceutical: Paradise Ultrasound Renal Denervation System for the Treatment of Resistant Hypertension, Now Covered by Insurance and Commercially Available in Japan Businesswire
02-Mar-2026 Faron and City of Hope in Process of Developing a Phase II Investigator-Initiated Trial of Bexmarilimab in Relapsed/Refractory MDS ACCESS Newswire
02-Mar-2026 Genflow Biosciences PLC Announces Receipt of First Tranche of Grant ACCESS Newswire
28-Feb-2026 WELIREG® (belzutifan) Plus LENVIMA® (lenvatinib) Reduced the Risk of Disease Progression or Death by 30% Compared to Cabozantinib in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma (RCC) Businesswire
28-Feb-2026 KIRIN HYOKETSU Expands into U.S. RTD Market with Local Production Businesswire
28-Feb-2026 Biocytogen Announces Clinical Milestone with First Patient Dosed in Phase 1 Trial of IDEAYA’s First-in-Class B7H3/PTK7 Bispecific TOP1 ADC IDE034 Businesswire
28-Feb-2026 Biocytogen Announces Clinical Milestone with First Patient Dosed in Phase 1 Trial of IDEAYA’s First-in-Class B7H3/PTK7 Bispecific TOP1 ADC IDE034 Businesswire
28-Feb-2026 IQVIA Releases its 2025 Sustainability Report Businesswire
28-Feb-2026 Prothena Announces up to $100 Million Share Repurchase Plan Businesswire
27-Feb-2026 EOSE Investigation Alert: BFA Law Investigates Eos Energy After Over 39% Stock Drop Businesswire